A glucose-containing ether lipid (Glc-PAF) as an antiproliferative analogue of the platelet-activating factor

被引:0
作者
Mickeleit, M
Wieder, T
Arnold, M
Geilen, CC
Mulzer, J
Reutter, W
机构
[1] Free Univ Berlin, Inst Mol Biol & Biochem, D-14195 Berlin, Germany
[2] Univ Vienna, Inst Organ Chem, A-1010 Vienna, Austria
[3] Free Univ Berlin, Inst Organ Chem, D-1000 Berlin, Germany
[4] Free Univ Berlin, Klinikum Benjamin Franklin, Haut & Poliklin, D-1000 Berlin, Germany
关键词
apoptosis; glycosides; phospholipids; platelet-activating factor; proliferation inhibitors;
D O I
10.1002/(SICI)1521-3773(19980216)37:3<351::AID-ANIE351>3.0.CO;2-P
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
[No abstract available]
引用
收藏
页码:351 / 353
页数:3
相关论文
共 50 条
  • [31] The role of tumour necrosis factor-α (TNF-α) and platelet-activating factor (PAF) interaction on murine candidosis
    Kalkanci, A
    Kustimur, S
    Timlioglu, Ö
    Uluoglu, C
    MYCOSES, 2002, 45 (3-4) : 79 - 83
  • [32] Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection
    Caini, P.
    Guerra, C. Tosti
    Giannini, C.
    Giannelli, F.
    Gragnani, L.
    Petrarca, A.
    Solazzo, V.
    Monti, M.
    Laffi, G.
    Zignego, A. L.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (01) : 22 - 28
  • [33] MEASUREMENT OF HUMAN EMBRYO-DERIVED PLATELET-ACTIVATING FACTOR (PAF) USING A QUANTITATIVE BIOASSAY OF PLATELET-AGGREGATION
    COLLIER, M
    ONEILL, C
    AMMIT, AJ
    SAUNDERS, DM
    HUMAN REPRODUCTION, 1990, 5 (03) : 323 - 328
  • [34] Platelet-activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation
    Krause, K.
    Gimenez-Arnau, A.
    Martinez-Escala, E.
    Farre-Albadalejo, M.
    Abajian, M.
    Church, M. K.
    Maurer, M.
    ALLERGY, 2013, 68 (02) : 256 - 258
  • [35] Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism
    Huang, YH
    Schäfer-Elinder, L
    Wu, R
    Claesson, HE
    Frostegård, J
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 116 (02) : 326 - 331
  • [36] Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2)
    Stafforini, Diana M.
    CARDIOVASCULAR DRUGS AND THERAPY, 2009, 23 (01) : 73 - 83
  • [37] The effect of platelet-activating factor (PAF) on nasal airway resistance in healthy subjects is not mediated by nitric oxide
    Maniscalco, M
    Sofia, M
    Faraone, S
    Carratù, L
    ALLERGY, 2000, 55 (08) : 757 - 761
  • [38] Targeting the Platelet-Activating Factor Receptor (PAF-R): Antithrombotic and Anti-Atherosclerotic Nutrients
    Harishkumar, Rajendran
    Hans, Sakshi
    Stanton, Janelle E.
    Grabrucker, Andreas M.
    Lordan, Ronan
    Zabetakis, Ioannis
    NUTRIENTS, 2022, 14 (20)
  • [39] Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2)
    Diana M. Stafforini
    Cardiovascular Drugs and Therapy, 2009, 23 : 73 - 83
  • [40] The specific binding of the platelet-activating factor (PAF) receptor antagonist WEB 2086 and the benzodiazepine flunitrazepam to rat hepatocytes
    Svetlov, SI
    Barton, JM
    Olson, MS
    LIFE SCIENCES, 1995, 58 (05) : PL81 - PL86